Related references
Note: Only part of the references are listed.Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA
Mary Jo Lund et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation
K. A. Metcalfe et al.
BRITISH JOURNAL OF CANCER (2009)
Genetic Predisposition to Breast Cancer: Past, Present, and Future
Clare Turnbull et al.
Annual Review of Genomics and Human Genetics (2008)
Classification of Rare Missense Substitutions, Using Risk Surfaces, With Genetic- and Molecular-Epidemiology Applications
Sean V. Tavtigian et al.
HUMAN MUTATION (2008)
Assessment of Functional Effects of Unclassified Genetic Variants
Fergus J. Couch et al.
HUMAN MUTATION (2008)
Performance of BRCA1/2 mutation prediction models in Asian Americans
Allison W. Kurian et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Evaluation of unclassified variants in the breast cancer susceptibility genes BRCA1 and BRCA2 using five methods: results from a population-based study of young breast cancer patients
Eunjung Lee et al.
BREAST CANCER RESEARCH (2008)
Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups
Esther M. John et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations
James D. Fackenthal et al.
NATURE REVIEWS CANCER (2007)
BRCA1 and BRCA2 genetic testing in Hispanic patients:: Mutation prevalence and evaluation of the BRCAPRO risk assessment model
Kristen J. Vogel et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2
Noah D. Kauff et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations
Sei Hyun Ahn et al.
CANCER LETTERS (2007)
Founder mutations in BRCA1 and BRCA2 genes
R. Ferla et al.
ANNALS OF ONCOLOGY (2007)
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer
Bruce G. Haffty et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years
Kathleen E. Malone et al.
CANCER RESEARCH (2006)
Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer
LJ Pierce et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epidemiology and the causes of breast cancer
B MacMahon
INTERNATIONAL JOURNAL OF CANCER (2006)
Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
Lyndsay N. Harris et al.
BREAST CANCER RESEARCH (2006)
Genetic testing in an ethnically diverse cohort of high-risk women -: A comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry
R Nanda et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Incidence of BRCA1 and BRCA2 mutations in young Korean breast cancer patients
DH Choi et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group
TR Rebbeck et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility
SS Bruinooge
JOURNAL OF CLINICAL ONCOLOGY (2003)
Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.
ND Kauff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers:: a case-control study
SA Narod et al.
LANCET (2000)
Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer
Q Gao et al.
HUMAN GENETICS (2000)
Share Paper
